[
    [
        {
            "time": "",
            "original_text": "创 新 药 产 业 深 度 报 告 暨 2 0 1 8 年 投 资 策 略 ： 拥 抱 医 药 创 新 的 新 时 代",
            "features": {
                "keywords": [
                    "创新药",
                    "产业深度报告",
                    "投资策略",
                    "医药创新"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "创 新 药 产 业 深 度 报 告 暨 2 0 1 8 年 投 资 策 略 ： 拥 抱 医 药 创 新 的 新 时 代",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "【 医 药 】 由 “ 仿 ” 入 “ 创 ” ， 创 新 开 启 新 的 时 代 红 利",
            "features": {
                "keywords": [
                    "医药",
                    "仿创结合",
                    "创新红利"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【 医 药 】 由 “ 仿 ” 入 “ 创 ” ， 创 新 开 启 新 的 时 代 红 利",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]